000 01540 a2200397 4500
005 20250515044215.0
264 0 _c20071127
008 200711s 0 0 eng d
022 _a0167-6806
024 7 _a10.1007/s10549-006-9399-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFrankel, Lisa B
245 0 0 _aProtein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.
_h[electronic resource]
260 _bBreast cancer research and treatment
_cAug 2007
300 _a165-79 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aBiomarkers, Tumor
_xmetabolism
650 0 4 _aBlotting, Western
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aDrug Resistance, Neoplasm
_xgenetics
650 0 4 _aEstrogen Antagonists
_xpharmacology
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHumans
650 0 4 _aImmunoprecipitation
650 0 4 _aOligonucleotides
_xpharmacology
650 0 4 _aProtein Kinase C-alpha
_xantagonists & inhibitors
650 0 4 _aTamoxifen
_xpharmacology
700 1 _aLykkesfeldt, Anne E
700 1 _aHansen, Jens B
700 1 _aStenvang, Jan
773 0 _tBreast cancer research and treatment
_gvol. 104
_gno. 2
_gp. 165-79
856 4 0 _uhttps://doi.org/10.1007/s10549-006-9399-1
_zAvailable from publisher's website
999 _c16635892
_d16635892